BIOCEPT INC Business Finance Contracts & Agreements
98 Contracts & Agreements
- Assignment Agreements (5 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (6)
- Note Agreements (10)
- Purchase Agreements (7)
- Registration Rights Agreements (1)
- Security Agreements (1)
- Stock Agreements (10)
- Subordination Agreement (1)
- Underwriting Agreements (8)
- Warrant Agreements (48)
- Form of Underwriting Agreement (Filed With SEC on May 23, 2023)
- Form of Common Stock Warrant (Filed With SEC on May 19, 2023)
- Form of Common Stock Warrant (Filed With SEC on May 16, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on May 15, 2023)
- Form of Common Stock Warrant (Filed With SEC on May 15, 2023)
- Form of Underwriting Agreement (Filed With SEC on May 15, 2023)
- Purchase Agreement, dated April 10, 2023 by and between Biocept, Inc. and the purchaser named therein (Filed With SEC on April 10, 2023)
- Second Amendment to Assignment and Exclusive Cross-License Agreement with Aegea, dated May 22, 2022, by and between Biocept, Inc. and Aegea Biotechnologies (Filed With SEC on November 10, 2022)
- Description of Common Stock (Filed With SEC on April 5, 2022)
- Specimen Common Stock certificate of Biocept, Inc (Filed With SEC on November 16, 2020)
- Description of Common Stock (Filed With SEC on March 27, 2020)
- Form of New Warrant (Filed With SEC on January 9, 2020)
- Form of Warrant Amendment (Filed With SEC on January 9, 2020)
- Form of Common Stock Warrant (Filed With SEC on December 11, 2019)
- Form of Common Stock Warrant (Filed With SEC on December 6, 2019)
- Form of Common Stock Warrant (Filed With SEC on December 5, 2019)
- Form of Underwriting Agreement (Filed With SEC on November 15, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 8, 2019)
- Form of Common Stock Warrant (Filed With SEC on November 8, 2019)
- Amendment to Warrant Exercise Agreement (Filed With SEC on July 18, 2019)
- Form of Warrant Exercise Agreement (Filed With SEC on May 29, 2019)
- Form of New Warrant (Filed With SEC on May 29, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on March 18, 2019)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on March 18, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on January 18, 2019)
- Form of Underwriting Agreement (Filed With SEC on December 10, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on November 28, 2018)
- Form of Series B Common Stock Warrant (Filed With SEC on November 28, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on September 24, 2018)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on September 24, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on September 24, 2018)
- Warrant Agency Agreement, dated as of August 13, 2018, by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on August 13, 2018)
- Form of Warrant to Purchase Common Stock (Filed With SEC on January 30, 2018)
- Form of Warrant to Purchase Common Stock (Filed With SEC on January 24, 2018)
- Common Stock Purchase Warrant issued by the Registrant in favor of Dawson James Securities, Inc. under the Securities Purchase Agreement dated December 5, 2017 (Filed With SEC on January 22, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on December 6, 2017)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 14, 2017)
- BIOCEPT, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on August 10, 2017)
- COMMON STOCK PURCHASE WARRANT BIOCEPT, INC. (Filed With SEC on August 10, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 30, 2017)
